Magnetic resonance imaging-based risk calculators optimize selection for prostate biopsy among biopsy-naive men

Cancer. 2022 Jan 1;128(1):25-27. doi: 10.1002/cncr.33872. Epub 2021 Aug 24.

Authors

Andrew M Fang¹, Soroush Rais-Bahrami^{1

2

3}

Affiliations

¹ Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama.
² Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
³ O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

PMID: 34427940
DOI: 10.1002/cncr.33872

No abstract available

Keywords: MRI; nomogram; prostate biopsy; prostate cancer; risk calculator.

Publication types

Editorial
Comment

MeSH terms

Biopsy
Humans
Magnetic Resonance Imaging
Male
Prostate* / diagnostic imaging
Prostate* / pathology
Prostate-Specific Antigen*

Substances

Prostate-Specific Antigen